ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
| 20.74 Data as of 12:33pm ET |  +0.48 / +2.37%Today’s Change | 15.64 Today|||52-Week Range 32.00 | -17.01% Year-to-Date |
Latest ACAD News | Press Releases
No recent news for ACADIA Pharmaceuticals Inc.
Today’s Trading
| Previous close | 20.26 |
| Today’s open | 20.02 |
| Day’s range | 20.02 - 20.98 |
| Volume | 285,302 |
| Average volume (3 months) | 1,201,134 |
| Market cap | $2.0B |
| Dividend yield | -- |
Data as of 12:33pm ET, 07/29/2014
Growth & Valuation
| Earnings growth (last year) | -15.79% |
| Earnings growth (this year) | -80.68% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -76.67% |
| P/E ratio | NM |
| Price/Sales | 1,870.76 |
| Price/Book | 10.13 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IPXLImpax Laboratories I... | -4.13 | -14.73% |
| IRWDIronwood Pharmaceuti... | +0.30 | +1.99% |
| WXWuXi Pharmatech (Cay... | +0.11 | +0.33% |
| GWPHGW Pharmaceuticals P... | +3.74 | +4.43% |
Data as of 12:47pm ET, 07/29/2014
Financials
| Next reporting date | August 6, 2014 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $1.1M |
| Annual profit (last year) | -$37.9M |
| Net profit margin | -3,314.24% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, CEO, Director & CAO Uli Hacksell |
Executive VP, Chief Financial & Business Officer Stephen R. Davis |
Corporate headquarters San Diego, California |
Forecasts
